Saturday 6 March 2021
Home      All news      Contact us      RSS     
healtheuropa - 1 month ago

A novel treatment for cytokine storm

Tetra Bio-Pharma’s drug ARDS-003 has been cleared by the FDA for human trials to target sepsis and ARDS. IT has been months in the making, but biopharmaceutical company Tetra Bio-Pharma has received the green light from the US Food and Drug Administration (FDA) to begin a Phase 1 trial with human subjects for its investigational [ ] The post A novel treatment for cytokine storm appeared first on Health Europa.


Latest News
Hashtags:   

novel

 | 

treatment

 | 

cytokine

 | 

storm

 | 

Sources